Pathogen Detection in Swine: 164 Samples Redefine Farm Tests
A field study of clinically sick pigs on commercial farms shows that matching molecular pathogen detection with microbial community profiling changes how a herd is read. The work points to oral fluid as a practical, high-diversity sample for routine monitoring.
Quick answer
Molecular diagnostics and microbiome profiling from the same sick pigs give a clearer picture than either method alone. In 164 field samples, lung tissue showed the lowest microbial diversity while oral fluid carried the richest, most monitorable community. Pairing a positive pathogen result with its microbial context supports faster, more targeted treatment decisions on commercial swine farms.
Why pathogen detection in swine needs more than a single test
Respiratory and enteric disease drive most treatment events in intensive pig production. A sick animal rarely carries one organism in isolation. Bacteria, viruses, and the resident microbial community interact, and the same clinical sign can come from very different combinations of agents. That is why pathogen detection in swine must look past a bare “present or absent” result, which leaves the herd manager with an incomplete map.
The study took clinically symptomatic pigs from commercial swine farms and ran two layers of testing on the same animals. One layer used molecular assays for the major respiratory and enteric pathogens. The other used 16S rRNA gene sequencing to describe the microbial community in lung, oral fluid, and fecal samples. Reading the two layers together is what makes the findings useful for farm-level decisions.
How the sampling was built
The design kept the three sample types separate so the microbial picture of each site could be compared directly.
| Element | Detail |
|---|---|
| Animals | Clinically symptomatic pigs from commercial swine farms |
| Sample types | Lung, oral fluid, fecal |
| Final sample count | 164 (lung 19, oral fluid 66, fecal 79) |
| Excluded | 1 lung and 1 oral fluid sample below 1,000 reads after quality filtering |
| Method, pathogens | Molecular diagnostics for major respiratory and enteric agents |
| Method, microbiome | 16S rRNA amplicon sequencing, QIIME 2 classify-sklearn |
| Statistics | Welch t-test with 95% CI; PERMANOVA; LEfSe |
Sequencing quality was high, with 88.82% of base calls above Q30 and an error rate of 2.11%. The PhiX spike-in sat at 20% by volume, a standard load for balanced community recovery.
What the pathogen screen found
Detection rates differed sharply by sample type, which matters for choosing where to test.
| Pathogen | Lung | Oral fluid | Fecal |
|---|---|---|---|
| PRRSV | 60.6% | 53.7% | not reported |
| PCV2 | 39.4% | 43.3% | not reported |
| P. multocida | 18.2% | 76.1% | not reported |
| PCV3 | 15.2% | 47.8% | not reported |
| A. pleuropneumoniae | 6.1% | 32.8% | not reported |
| Rotavirus | not reported | not reported | 43.0% |
| C. perfringens | not reported | not reported | 30.4% |
| Pathogenic E. coli | not reported | not reported | 25.3% |
Two patterns stand out. First, PRRSV was the most detected respiratory agent in both lung and oral fluid, which fits its role as a herd-level driver. Second, oral fluid caught P. multocida in 76.1% of samples, far above the lung figure, suggesting oral fluid is a sensitive window onto upper-respiratory carriage that lung tissue alone would miss.
The microbial community told its own story
Alpha diversity confirmed that the lower respiratory tract is a narrow, stressed environment. Lung samples had significantly lower species diversity than oral fluid and fecal samples, with both comparisons at p less than 0.001. Oral fluid and fecal samples did not differ from each other on diversity (p greater than 0.05), even though their community structures were distinct.
Beta diversity separated the three sample types into three clear clusters (F = 19.476, R2 = 0.19481, p = 0.001), and every pairwise comparison held at p = 0.001. At the genus level, lung samples were dominated by a few taxa: Escherichia-Shigella at 18.11%, Actinobacillus at 14.45%, and Mycoplasma at 7.05%. Fecal samples told a different story, with Firmicutes at 40.63% and Bacteroidota at 42.97%, and Prevotellaceae the leading family at 31.26%.
The counterintuitive finding: one pathogen reshaped the gut
Of all agents tested, Clostridium perfringens was the only one with a consistent association to both microbial diversity and community composition. C. perfringens-positive fecal samples differed on Chao1 (p = 0.017) and on PERMANOVA (p = 0.010), and the signal held on re-check (Chao1 p = 0.007, PERMANOVA p = 0.017). Other pathogens showed weaker or non-repeating links.
This is the practical twist. A routine pathogen panel reports C. perfringens as present or absent. The microbiome layer shows that its presence tracks a shifted gut community with predicted changes in nutrient acquisition and microbial competition pathways. For a producer, that context changes the question from “do we treat” to “what else in the gut environment are we treating alongside it.”
What this means for on-farm decisions
Early diagnostic information supports timely interventions. The study notes that a positive result lets a farm move faster on enhanced biosecurity, such as quarantine, isolation of affected animals, movement restrictions, and disinfection, and on targeted treatment rather than blanket coverage. From a wider view, those measures also lower the risk of pathogen spread beyond the farm and support more careful antimicrobial use.
For producers and their veterinarians, three steps follow directly:
- Run molecular pathogen panels on clinically affected animals instead of relying on signs alone, because co-infection is common and changes the treatment plan.
- Include oral fluid in routine monitoring, since it carries high diversity and catches upper-respiratory carriage that lung sampling misses.
- Read a positive pathogen result next to its microbial community context, especially for C. perfringens, before settling on a treatment course.
Limitations to keep in view
The study worked with clinically affected animals and had no healthy control group, so disease-associated microbiome shifts cannot be separated from baseline farm variation. The absence of healthy controls also limits how strongly any single taxon can be called a biomarker. Findings come from field conditions, which is a strength for relevance but a caveat for causal claims.
Bottom line
Pathogen detection in swine becomes far more useful when molecular results and microbial community data are read from the same animal. The 164-sample field set shows oral fluid as a high-value monitoring matrix and C. perfringens as the pathogen most tied to gut community change. Pairing the two layers is a practical step toward faster, more targeted, and more measured treatment on commercial pig farms.
FAQ
What pathogens were most common in the sick pigs?
PRRSV led respiratory detection at 60.6% in lung and 53.7% in oral fluid, while P. multocida reached 76.1% in oral fluid. In fecal samples rotavirus was highest at 43.0%, followed by C. perfringens at 30.4% and pathogenic E. coli at 25.3%. The mix shows co-infection is the rule rather than the exception on commercial swine farms.
Why use oral fluid instead of lung tissue for monitoring?
Oral fluid carried microbial diversity comparable to fecal samples and caught upper-respiratory carriage that lung tissue missed, with P. multocida at 76.1% versus 18.2% in lung. It is also easier to collect repeatedly without sacrificing animals. The study treats oral fluid as a practical, high-information matrix for routine herd monitoring.
How many samples were analyzed in the study?
The final microbiome dataset held 164 samples: 19 lung, 66 oral fluid, and 79 fecal specimens from clinically symptomatic pigs. Two samples were excluded for low sequencing depth below 1,000 reads after quality filtering. High sequencing quality supported the community comparisons drawn from this set.
What is the difference between alpha and beta diversity here?
Alpha diversity measured species richness within one sample type, and lung scored significantly lower than oral fluid and fecal at p less than 0.001. Beta diversity measured community differences across sample types and separated lung, oral fluid, and fecal into three clusters at p = 0.001. Together they show the lung is a narrow, stressed microbial environment.
Which bacterium was linked to gut community change?
Clostridium perfringens was the only pathogen with a consistent link to both diversity and composition in fecal samples, significant on Chao1 at p = 0.017 and PERMANOVA at p = 0.010. The association held on re-check at p = 0.007 and p = 0.017. Its positive status tracked predicted shifts in nutrient and competition pathways.
Does the study prove cause and effect?
No. The work is observational and field-based, with no healthy control group to separate disease signals from baseline variation. It shows association, not causation, between pathogen status and microbial community structure. The authors frame the microbiome findings as supportive context for diagnosis rather than proof of mechanism.
What dominated the lung microbial community?
Lung samples were dominated by a small set of genera: Escherichia-Shigella at 18.11%, Actinobacillus at 14.45%, and Mycoplasma at 7.05%. This narrow profile contrasts with the even, diverse communities in oral fluid and feces. The pattern marks the lower respiratory tract as a low-diversity, infection-prone site.
How were the pathogens detected?
For pathogen detection in swine, major respiratory and enteric pathogens were identified with molecular diagnostic assays run on the same animals used for microbiome profiling. Detection rates were reported per sample type after quality filtering. The dual method let the team compare a positive pathogen result with the microbial community of that sample.
Why does co-infection matter for treatment?
Co-infection changes both disease severity and the right treatment course, because a virus can open the door for bacterial invasion or worsen a known bacterium’s effect. A single positive result therefore understates the field picture. Reading pathogen status with the microbial community helps target therapy instead of broad coverage.
Can these findings guide antimicrobial use?
The study argues that faster, field-based diagnosis supports timely isolation and targeted treatment, which in turn promotes more careful antimicrobial use. It does not recommend specific drugs. The value is in narrowing the decision from blanket coverage to a measured, evidence-based response on the farm.
What were the fecal community dominants?
Fecal samples were led by Firmicutes at 40.63% and Bacteroidota at 42.97%, with Prevotellaceae the top family at 31.26% and Prevotella the leading genus at 14.66%. This even, plant-fiber-linked profile differs sharply from the lung’s narrow pathogen-heavy community. The contrast reflects the distinct ecology of the gut.
How should a farm apply this work?
A farm should add molecular pathogen panels on sick animals, include oral fluid in routine monitoring, and read positive results next to microbiome context before treating. The study supports moving from sign-based guessing to layered, field-ready diagnosis. That shift backs both animal health and steadier antimicrobial stewardship.
